Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.

Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ. · 2018

Read Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. by Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5813086.txt.

Description

Carhart-Harris and co-authors follow psilocybin therapy for hard-to-treat depression. Psilocybin is the active part of magic mushrooms. Early trials hinted at fast, strong relief. This report tracks patients for six months after dosing.

Twenty patients with severe, stubborn depression took part. Each got two oral doses, 10 and 25 milligrams, a week apart. Support staff sat with them through each session. Symptoms fell sharply within one week. Nine patients met response marks at week five. Gains held, though softer, at six months. No one sought standard drugs in the first five weeks. Readers get careful early proof, not a final verdict.

Catalog record

CREATORCarhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE43 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5813086

Browse the full library · About the Tower of Babel